Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03647267 · ClinicalTrials.gov registry record · Phase 3
Effects of Pneumatic Vitreolysis on Vitreomacular Traction
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 46
- Enrollment target
NCT03647267 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 46 participants.
The verdict
NCT03647267, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 46 participants
- Enrollment target
Study Summary
Eyes with idiopathic symptomatic vitreomacular traction (VMT) without a macular hole will be randomly assigned to 0.3-mL intraocular gas (C3F8) injection or sham injection to determine if pneumatic vitreolysis (PVL) is effective in releasing VMT.
Interventions
- OTHER Observation
- DEVICE Pneumatic Vitreolysis (C3F8 injection)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2020-08-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03647267
The ClinicalTrials.gov registry entry for NCT03647267 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Observation is the first listed.
NCT03647267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03647267 about?
NCT03647267 is a clinical study titled "Effects of Pneumatic Vitreolysis on Vitreomacular Traction". Eyes with idiopathic symptomatic vitreomacular traction (VMT) without a macular hole will be randomly assigned to 0.3-mL intraocular gas (C3F8) injection or sham injection to determine if pneumatic vitreolysis (PVL) is effective in releasing VMT.
What is the current status of trial NCT03647267?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 46 participants. The study started on 2018-10-16. Estimated completion is 2020-08-06.
What interventions are being tested in trial NCT03647267?
The interventions under investigation include: Observation (OTHER), Pneumatic Vitreolysis (C3F8 injection) (DEVICE).
Who is sponsoring clinical trial NCT03647267?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.